Timothy J. Hohman, Ph.D. - Related publications

2012 Psychology American University, Washington, DC, United States 
Cognitive Psychology, Neuroscience Biology, Aging
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Teylan M, Mock C, Gauthreaux K, Chen YC, Chan KCG, Hassenstab J, Besser LM, Kukull WA, Crary JF. Cognitive trajectory in mild cognitive impairment due to primary age-related tauopathy. Brain : a Journal of Neurology. PMID 31942622 DOI: 10.1093/brain/awz403   
2020 Sripanidkulchai B. Benefits of aged garlic extract on Alzheimer's disease: Possible mechanisms of action. Experimental and Therapeutic Medicine. 19: 1560-1564. PMID 32010339 DOI: 10.3892/etm.2019.8390   
2020 Dawe RJ, Yu L, Arfanakis K, Schneider JA, Bennett DA, Boyle PA. Late-life cognitive decline is associated with hippocampal volume, above and beyond its associations with traditional neuropathologic indices. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 209-218. PMID 31914231 DOI: 10.1002/alz.12009   
2020 Chandler HL, Hodgetts CJ, Caseras X, Murphy K, Lancaster TM. Polygenic risk for Alzheimer's disease shapes hippocampal scene-selectivity. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 31896120 DOI: 10.1038/s41386-019-0595-1   
2020 Lin CY, Chen CH, Tom SE, Kuo SH, . Cerebellar Volume Is Associated with Cognitive Decline in Mild Cognitive Impairment: Results from ADNI. Cerebellum (London, England). PMID 31900856 DOI: 10.1007/s12311-019-01099-1   
2020 Walker KA, Gross AL, Moghekar AR, Soldan A, Pettigrew C, Hou X, Lu H, Alfini AJ, Bilgel M, Miller MI, Albert MS, Walston J. Association of peripheral inflammatory markers with connectivity in large-scale functional brain networks of non-demented older adults. Brain, Behavior, and Immunity. PMID 31935468 DOI: 10.1016/j.bbi.2020.01.006   
2020 Weigand AJ, Bangen KJ, Thomas KR, Delano-Wood L, Gilbert PE, Brickman AM, Bondi MW, . Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity. Brain Communications. 2: fcz046. PMID 32051933 DOI: 10.1093/braincomms/fcz046   
2020 Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, DeBuc DC, Cordeiro F, Provetti-Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ. Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 229-243. PMID 31914225 DOI: 10.1002/alz.12006   
2020 Pereira JB, Harrison TM, La Joie R, Baker SL, Jagust WJ. Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. European Journal of Nuclear Medicine and Molecular Imaging. PMID 31915896 DOI: 10.1007/s00259-019-04669-x   
2020 Xiong C, Luo J, Coble D, Agboola F, Kukull W, Morris JC. Complex interactions underlie racial disparity in the risk of developing Alzheimer's disease dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32067357 DOI: 10.1002/alz.12060   
2020 Vermunt L, Muniz-Terrera G, Ter Meulen L, Veal C, Blennow K, Campbell A, Carrié I, Delrieu J, Fauria K, Huesa Rodríguez G, Ingala S, Jenkins N, Molinuevo JL, Ousset PJ, Porteous D, ... , et al. Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings. Alzheimer's Research & Therapy. 12: 8. PMID 31907067 DOI: 10.1186/s13195-019-0576-y   
2020 Javed M, Ahmad MI, Javed H, Naseem S. D-ribose and pathogenesis of Alzheimer's disease. Molecular Biology Reports. PMID 31933261 DOI: 10.1007/s11033-020-05243-7   
2020 Byun MS, Jung JH, Sohn BK, Yi D, Lee JH, Jeon SY, Lee Y, Jung GJ, Lee JY, Kim YK, Shin SA, Sohn CH, Kang KM, Lee DY, . Neuroticism, conscientiousness, and in vivo Alzheimer pathologies measured by amyloid PET and MRI. Psychiatry and Clinical Neurosciences. PMID 31985106 DOI: 10.1111/pcn.12983   
2020 Polis B, Samson AO. Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders. Neural Regeneration Research. 15: 1460-1470. PMID 31997805 DOI: 10.4103/1673-5374.274328   
2020 Lin C, Ly M, Karim HT, Wei W, Snitz BE, Klunk WE, Aizenstein HJ. The effect of amyloid deposition on longitudinal resting-state functional connectivity in cognitively normal older adults. Alzheimer's Research & Therapy. 12: 7. PMID 31907079 DOI: 10.1186/s13195-019-0573-1   
2020 Raman S, Brookhouser N, Brafman DA. Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer's disease (AD) risk. Neurobiology of Disease. 104788. PMID 32032733 DOI: 10.1016/j.nbd.2020.104788   
2020 Gomez W, Morales R, Maracaja-Coutinho V, Parra V, Nassif M. Down syndrome and Alzheimer's disease: common molecular traits beyond the amyloid precursor protein. Aging. 11. PMID 31918411 DOI: 10.18632/aging.102677   
2020 McKenzie C, Bucks RS, Weinborn M, Bourgeat P, Salvado O, Gavett BE, . Cognitive reserve predicts future executive function decline in older adults with Alzheimer's disease pathology but not age-associated pathology. Neurobiology of Aging. PMID 31980279 DOI: 10.1016/j.neurobiolaging.2019.12.022   
2020 Cohen D, Pilozzi A, Huang X. Network Medicine Approach for Analysis of Alzheimer's Disease Gene Expression Data. International Journal of Molecular Sciences. 21. PMID 31947790 DOI: 10.3390/ijms21010332   
2020 Yan T, Liang J, Gao J, Wang L, Fujioka H, , Zhu X, Wang X. FAM222A encodes a protein which accumulates in plaques in Alzheimer's disease. Nature Communications. 11: 411. PMID 31964863 DOI: 10.1038/s41467-019-13962-0   
2020 Jääskeläinen O, Hall A, Tiainen M, van Gils M, Lötjönen J, Kangas AJ, Helisalmi S, Pikkarainen M, Hallikainen M, Koivisto A, Hartikainen P, Hiltunen M, Ala-Korpela M, Soininen P, Soininen H, et al. Metabolic Profiles Help Discriminate Mild Cognitive Impairment from Dementia Stage in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 32007958 DOI: 10.3233/JAD-191226   
2020 Chen TB, Lai YH, Ke TL, Chen JP, Lee YJ, Lin SY, Lin PC, Wang PN, Cheng IH. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease. Dementia and Geriatric Cognitive Disorders. 1-16. PMID 31991443 DOI: 10.1159/000505435   
2020 Jeon Y, Lee JH, Choi B, Won SY, Cho KS. Genetic Dissection of Alzheimer's Disease Using Models. International Journal of Molecular Sciences. 21. PMID 32019113 DOI: 10.3390/ijms21030884   
2020 Caunca MR, Siedlecki K, Cheung YK, Alperin N, Lee SH, Elkind MSV, Sacco RL, Wright CB, Rundek T. Cholinergic White Matter Lesions, AD-Signature Cortical Thickness, and Change in Cognition: The Northern Manhattan Study. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. PMID 31944231 DOI: 10.1093/gerona/glz279   
2020 Ivanova N, Liu Q, Agca C, Agca Y, Noble EG, Whitehead SN, Cechetto DF. White matter inflammation and cognitive function in a co-morbid metabolic syndrome and prodromal Alzheimer's disease rat model. Journal of Neuroinflammation. 17: 29. PMID 31964387 DOI: 10.1186/s12974-020-1698-7   
2020 Williams T, Borchelt DR, Chakrabarty P. Therapeutic approaches targeting Apolipoprotein E function in Alzheimer's disease. Molecular Neurodegeneration. 15: 8. PMID 32005122 DOI: 10.1186/s13024-020-0358-9   
2020 Cannavo C, Tosh J, Fisher EMC, Wiseman FK. Using mouse models to understand Alzheimer's disease mechanisms in the context of trisomy of chromosome 21. Progress in Brain Research. 251: 181-208. PMID 32057307 DOI: 10.1016/bs.pbr.2019.10.004   
2020 Ferreira D, Nordberg A, Westman E. Biological subtypes of Alzheimer disease: A systematic review and meta-analysis. Neurology. PMID 32047067 DOI: 10.1212/WNL.0000000000009058   
2020 Martersteck A, Sridhar J, Rader B, Coventry C, Parrish T, Mesulam MM, Rogalski E. Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease. Neurology. PMID 31969462 DOI: 10.1212/WNL.0000000000008960   
2020 Malampati S, Song JX, Chun-Kit Tong B, Nalluri A, Yang CB, Wang Z, Gopalkrishnashetty Sreenivasmurthy S, Zhu Z, Liu J, Su C, Krishnamoorthi S, Iyaswamy A, Cheung KH, Lu JH, Li AM. Targeting Aggrephagy for the Treatment of Alzheimer's Disease. Cells. 9. PMID 32012902 DOI: 10.3390/cells9020311   
2020 Duchaine CS, Talbot D, Nafti M, Giguère Y, Dodin S, Tourigny A, Carmichael PH, Laurin D. Vitamin D status, cognitive decline and incident dementia: the Canadian Study of Health and Aging. Canadian Journal of Public Health = Revue Canadienne De Sante Publique. PMID 32016921 DOI: 10.17269/s41997-019-00290-5   
2020 Zhang Y, Li Y, Wang R, Sha G, Jin H, Ma L. Elevated Urinary AD7c-NTP Levels in Older Adults with Hypertension and Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 32007954 DOI: 10.3233/JAD-190944   
2020 Reale M, Costantini E, Jagarlapoodi S, Khan H, Belwal T, Cichelli A. Relationship of Wine Consumption with Alzheimer's Disease. Nutrients. 12. PMID 31941117 DOI: 10.3390/nu12010206   
2020 Westwood S, Baird AL, Anand SN, Nevado-Holgado AJ, Kormilitzin A, Shi L, Hye A, Ashton NJ, Morgan AR, Bos I, Vos SJB, Baker S, Buckley NJ, Ten Kate M, Scheltens P, et al. Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort. Journal of Alzheimer's Disease : Jad. PMID 31985466 DOI: 10.3233/JAD-190434   
2020 Wisniewski T, Drummond E. APOE-amyloid interaction: Therapeutic targets. Neurobiology of Disease. 104784. PMID 32027932 DOI: 10.1016/j.nbd.2020.104784   
2020 McSweeney M, Pichet Binette A, Meyer PF, Gonneaud J, Bedetti C, Ozlen H, Labonté A, Rosa-Neto P, Breitner J, Poirier J, Villeneuve S, . Intermediate flortaucipir uptake is associated with Aβ-PET and CSF-tau in asymptomatic adults. Neurology. PMID 32015176 DOI: 10.1212/WNL.0000000000008905   
2020 Whitwell JL, Tosakulwong N, Weigand SD, Graff-Radford J, Duffy JR, Clark HM, Machulda MM, Botha H, Utianski RL, Schwarz CG, Senjem ML, Strand EA, Ertekin-Taner N, Jack CR, Lowe VJ, et al. Longitudinal Amyloid-β PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration. Journal of Alzheimer's Disease : Jad. PMID 32039841 DOI: 10.3233/JAD-190699   
2020 Lu G, Liu W, Huang X, Zhao Y. Complement factor H levels are decreased and correlated with serum C-reactive protein in late-onset Alzheimer's disease. Arquivos De Neuro-Psiquiatria. PMID 32022122 DOI: 10.1590/0004-282X20190151   
2020 Castanho I, Murray TK, Hannon E, Jeffries A, Walker E, Laing E, Baulf H, Harvey J, Bradshaw L, Randall A, Moore K, O'Neill P, Lunnon K, Collier DA, Ahmed Z, et al. Transcriptional Signatures of Tau and Amyloid Neuropathology. Cell Reports. 30: 2040-2054.e5. PMID 32049030 DOI: 10.1016/j.celrep.2020.01.063   
2020 Uddin MS, Kabir MT, Tewari D, Mathew B, Aleya L. Emerging signal regulating potential of small molecule biflavonoids to combat neuropathological insults of Alzheimer's disease. The Science of the Total Environment. 700: 134836. PMID 31704512 DOI: 10.1016/j.scitotenv.2019.134836   
2020 Calvo-Flores Guzmán B, Kim S, Chawdhary B, Peppercorn K, Tate WP, Waldvogel HJ, Faull RL, Montgomery J, Kwakowsky A. Amyloid-Beta -Induced Increase in GABAergic Tonic Conductance in Mouse Hippocampal CA1 Pyramidal Cells. Molecules (Basel, Switzerland). 25. PMID 32041202 DOI: 10.3390/molecules25030693   
2020 Sierksma A, Lu A, Mancuso R, Fattorelli N, Thrupp N, Salta E, Zoco J, Blum D, Buée L, De Strooper B, Fiers M. Novel Alzheimer risk genes determine the microglia response to amyloid-β but not to TAU pathology. Embo Molecular Medicine. e10606. PMID 31951107 DOI: 10.15252/emmm.201910606   
2020 Schaffert J, LoBue C, White CL, Wilmoth K, Didehbani N, Lacritz L, Nguyen T, Peters ME, Fields L, Li C, Cullum CM. Risk factors for earlier dementia onset in autopsy-confirmed Alzheimer's disease, mixed Alzheimer's with Lewy bodies, and pure Lewy body disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32043803 DOI: 10.1002/alz.12049   
2020 Evans CE, Miners JS, Piva G, Willis CL, Heard DM, Kidd EJ, Good MA, Kehoe PG. ACE2 activation protects against cognitive decline and reduces amyloid pathology in the Tg2576 mouse model of Alzheimer's disease. Acta Neuropathologica. PMID 31982938 DOI: 10.1007/s00401-019-02098-6   
2020 Wilson EN, Swarovski MS, Linortner P, Shahid M, Zuckerman AJ, Wang Q, Channappa D, Minhas PS, Mhatre SD, Plowey ED, Quinn JF, Zabetian CP, Tian L, Longo FM, Cholerton B, et al. Soluble TREM2 is elevated in Parkinson's disease subgroups with increased CSF tau. Brain : a Journal of Neurology. PMID 32065223 DOI: 10.1093/brain/awaa021   
2020 Yang M, Li C, Zhang Y, Ren J. Interrelationship between Alzheimer's disease and cardiac dysfunction: the brain-heart continuum? Acta Biochimica Et Biophysica Sinica. PMID 31897470 DOI: 10.1093/abbs/gmz115   
2020 Wu Z, Palanimuthu D, Braidy N, Salikin NH, Egan S, Huang MLH, Richardson DR. Novel Multi-Functional Iron Chelators of the Aroyl Nicotinoyl Hydrazone Class that Markedly Enhance Cellular NAD/NADH Ratios. British Journal of Pharmacology. PMID 31895471 DOI: 10.1111/bph.14963   
2020 Derakhshankhah H, Sajadimajd S, Jafari S, Izadi Z, Sarvari S, Sharifi M, Falahati M, Moakedi F, Muganda WCA, Müller M, Raoufi M, Presley JF. Novel therapeutic strategies for Alzheimer's disease: Implications from cell-based therapy and Nanotherapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 102149. PMID 31927133 DOI: 10.1016/j.nano.2020.102149   
2020 Mahajan UV, Varma VR, Griswold ME, Blackshear CT, An Y, Oommen AM, Varma S, Troncoso JC, Pletnikova O, O'Brien R, Hohman TJ, Legido-Quigley C, Thambisetty M. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study. Plos Medicine. 17: e1003012. PMID 31978055 DOI: 10.1371/journal.pmed.1003012   
2020 Anderson EL, Howe LD, Wade KH, Ben-Shlomo Y, Hill WD, Deary IJ, Sanderson EC, Zheng J, Korologou-Linden R, Stergiakouli E, Davey Smith G, Davies NM, Hemani G. Education, intelligence and Alzheimer's disease: evidence from a multivariable two-sample Mendelian randomization study. International Journal of Epidemiology. PMID 32003800 DOI: 10.1093/ije/dyz280